share_log

Short Interest in SQI Diagnostics Inc. (OTCMKTS:SQIDF) Increases By 18.7%

kopsource ·  Nov 14, 2022 13:33

SQI Diagnostics Inc. (OTCMKTS:SQIDF – Get Rating) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 36,800 shares, an increase of 18.7% from the October 15th total of 31,000 shares. Based on an average daily volume of 159,500 shares, the days-to-cover ratio is presently 0.2 days.

SQI Diagnostics Price Performance

Shares of SQIDF remained flat at $0.08 during mid-day trading on Friday. 66,700 shares of the stock traded hands, compared to its average volume of 55,483. The business has a 50 day simple moving average of $0.08 and a 200-day simple moving average of $0.11. SQI Diagnostics has a twelve month low of $0.06 and a twelve month high of $0.18.

Get SQI Diagnostics alerts:

About SQI Diagnostics

(Get Rating)

SQI Diagnostics Inc, a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test.

Further Reading

  • Get a free copy of the StockNews.com research report on SQI Diagnostics (SQIDF)
  • S&P 500 Component DexCom Set For Further Price, Earnings Growth
  • MarketBeat: Week in Review 11/7 – 11/11
  • Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
  • Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
  • Six Flags is a Ride You Don't Want to Get Stuck On

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment